BioSpace News Archive

Deals

AVROBIO Announces Pricing of Underwritten Public Offering of $120.25 Million of Common Stock

AVROBIO, Inc., a Phase 2 clinical-stage gene therapy company, announced the pricing of an underwritten public offering of 6,500,000 shares of its common stock at a public offering price of $18.50 per share.

July 16, 2019
·
5 min read
Biotech Bay

NOTABLE ANNOUNCES $40M SERIES B ROUND TO FUEL DEVELOPMENT OF ITS DRUG DISCOVERY PLATFORM FOR PERSONALIZED ONCOLOGY

Notable, which is redefining cancer treatment with a clinically validated platform that rapidly advances cancer drug development at a fraction of the traditional time and cost, announced a $40M Series B round.

July 16, 2019
·
4 min read
Tornado Spectral Systems Completes $10.2 Million in Series A Financing

Tornado Spectral Systems Inc., a leading manufacturer of Raman analyzers for real-time process monitoring, today announced it has closed its latest round of Series A financing bringing a total of $10.2 million in new investment.

July 16, 2019
·
1 min read
Pharm Country

AbleTo and Horizon Healthcare Services, Inc. Partner to Bring Virtual Behavioral Health Care to Managed Medicaid Members

AbleTo, the market-leading provider of virtual behavioral health care, announced today the launch of a new program for Managed Medicaid members of Horizon Healthcare Services, Inc., New Jersey’s oldest and largest health insurer.

July 16, 2019
·
3 min read
Policy

Treat and Reduce Obesity Act Gains Support in the U.S. House of Representatives in Record Time

The 2019 Treat and Reduce Obesity Act (TROA) (S595) (HR1530) has surpassed 100 co-sponsors in the U.S. House of Representatives with a total of 112 legislators supporting the Act.

July 16, 2019
·
2 min read